Citation Impact
Citing Papers
A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules
2003 StandoutScience
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.
1997
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
2008
The DNA-damage response in human biology and disease
2009 StandoutNature
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
2008
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Smarter drugs emerging in pancreatic cancer therapy
2014
EGFR Antagonists in Cancer Treatment
2008 Standout
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
2007 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Liver and kidney preservation by perfusion
2002
Pancreatic cancer
2004 Standout
Inflammation and cancer
2002 StandoutNature
Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
1999
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor
2003
Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family
2002
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome
2006
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
2004
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
1997 Nature
Budd–Chiari syndrome: a review by an expert panel
2003
Central pontine myelinolysis with stupor alone after orthotopic liver transplantation
1996
Pancreatic cancer
2020 Standout
The Role of Venous and Arterial Resection in Pancreatic Cancer Surgery
2016
Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome
2001
The impact of serum sodium concentration on mortality after liver transplantation: A cohort multicenter study
2007
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Ten-Year Experience With 733 Pancreatic Resections
2001
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Cancer Metastasis: Building a Framework
2006 Standout
TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
2003
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1
2006
Classification of Surgical Complications
2004 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The prognostic value of histology in the assessment of patients with Budd–Chiari syndrome
2001
Pancreatic cancer
2016 Standout
Strategies for MMP inhibition in cancer: innovations for the post-trial era
2002
Molecular Biology of Pancreatic Cancer
2001
Multilineage hempoietic stem cell defects in Budd Chiari syndrome
1997
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature
2003
Pylorus Preservation Has No Impact on Delayed Gastric Emptying After Pancreatic Head Resection
2003
Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up
2000
Vascular disorders of the liver # †
2008 Standout
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
2003
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Amyloid Fibril Formation and Seeding by Wild-Type Human Lysozyme and Its Disease-Related Mutational Variants
2000
Pancreatic Adenocarcinoma
2014 Standout
Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definition
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Acetaminophen Toxicity in an Urban County Hospital
1997
The Toxicology of Mercury — Current Exposures and Clinical Manifestations
2003 Standout
Pathogenesis and Treatment of Budd-Chiari Syndrome Combined with Portal Vein Thrombosis
2006
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Angiogenesis in life, disease and medicine
2005 StandoutNature
Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation
2004
Infections in Liver Transplant Recipients
1995
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
2002
Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari
2003
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Percutaneous balloon angioplasty of inferior vena cava in Budd–Chiari syndrome-R1
2002
Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome
2000
Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature
2008
Outcomes of Adjuvant Chemoradiation After Pancreaticoduodenectomy With Mesenterico-Portal Vein Resection for Adenocarcinoma of the Pancreas
2009
Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome
2003
Liver transplantation for budd-chiari syndrome
2002
Update on Familial Pancreatic Cancer
2010
Classification of anticancer drugs—a new system based on therapeutic targets
2003
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Arterial and Venous Resection for Pancreatic Adenocarcinoma
2009
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis
2003
Small cell lung cancer: the importance of the extracellular matrix
2004
Clinicopathological forms and prognostic index in Budd-Chiari syndrome
2003
Pancreatic Cancer
2010 Standout
Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice
2010 StandoutNobel
Cyclosporine
1989 Standout
Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome
2005
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer
2005
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
2006
Infection in Organ-Transplant Recipients
1998 Standout
Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy
1993
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Molecular Mechanisms of Amyloidosis
2003 Standout
Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis : A Study From North India
2004
PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome
2004
Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia
2005
Pancreatic cancer
2011 Standout
The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt
2004
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
2005
Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis
1998
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
2004
Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery
2001
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Changes in pancreatic resection for chronic pancreatitis over 28 years in a single institution
2000
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
The Pancreas Cancer Microenvironment
2012
Inherited Prothrombotic Defects in Budd-Chiari Syndrome and Portal Vein Thrombosis
2004
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Primary hepatic malignancy: The role of liver transplantation
1990
Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products
2001
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Tools and Tactics for the Optical Detection of Mercuric Ion
2008 Standout
TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE PLAMINOGEN ACTIVATOR OR ORTHOTOPIC LIVER TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1
1996
Renal function in tyrosinaemia type I after liver transplantation: A long‐term follow‐up
2005
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection
1994
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
2004
Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297
2002
Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
2005
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005
Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study
2005
Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West
2004
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001
2008
Central Nervous System Toxicity after Liver Transplantation
1987
Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up
2005
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Works of J.A.C. Buckels being referenced
Serious paracetamol poisoning and the results of liver transplantation.
1994
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting
1999
'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis.
1996
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
2002
A phase II trial of marimastat in advanced pancreatic cancer
2001
Outcome of surgery for chronic pancreatitis
1997
Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors
2006
Clinical spectrum, investigations and treatment of Budd-Chiari syndrome
1996
Favourable Prognostic Factors in a Large UK Experience of Adenocarcinoma of the Head of the Pancreas and Periampullary Region
2004
Haemorrhage following Pancreaticoduodenectomy: Risk Factors and the Importance of Sentinel Bleed
2006
Correction of severe hyponatraemia by continuous arteriovenous haemofiltration before liver transplantation.
1988
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
2000
Diabetic control after total pancreatectomy
2006
CAN EFFLUENT HYALURONIC ACID OR CREATINE KINASE PREDICT SINUSOIDAL INJURY SEVERITY AFTER COLD ISCHEMIA?
1993
Indications and outcome of liver transplantation in tyrosinaemia type 1
1999
NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION
1987
Neuropathological findings in autopsies after liver transplantation.
1991
Long-term renal function in liver transplantation.
1991
Central pontine myelinolysis in liver transplantation.
1991
Orthotopic liver transplantation for hepatic GVHD following allogeneic BMT for chronic myeloid leukaemia.
1992
Molecular technology and pancreatic cancer
2000
Outcome of surgery for chronic pancreatitis
1997
Six of the Best, Upper GI 14
2002
Orthotopic liver transplantation: Postoperative complications and their management
1987
Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial.
1991
Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized Trial
2001
Cerebral aspergillosis in liver transplantation.
1990